|
Pma/510(k) # = p100022/s026.Cook ireland ltd (manufacturer) is submitting this report on behalf of cook medical incorporated (cmi)(importer).Exemption number: e2016031.Information pertaining to section g.1 as follows: importer site contact and address: (b)(4).Cook medical incorporated (cmi), 1025 acuff road, p.O box 4195, bloomington , indiana 47402-4195.Importer site establishment registration number: 3005580113.Device evaluation: the zisv6-35-125-6-140-ptx device of lot number c1572032 involved in this complaint was returned for evaluation, without the original packaging.With the information provided, a physical examination and document based investigation was conducted.Lab evaluation: the device related to this occurrence underwent a laboratory evaluation on the 25th april 2019.The returned device lab examination findings and observations can be referred through attached photos.Crinkling was observed on the stent retraction sheath (srs) and the retraction wire was found to be separated from the srs.Document review: prior to distribution zisv6-35-125-6-140-ptx devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zisv6-35-125-6-140-ptx of lot number c1572032 did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records, confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number c1572032.It should be noted that the instructions for use states the following: ¿precautions if resistance is met during advancement of the delivery system, do not force passage.Remove the delivery system and replace with a new device.¿ ¿a 0.035 inch (0.89mm) diameter wire guide should be used during tracking, deployment, and removal in order to ensure adequate support of the system.If hydrophilic wire guides are used, they must be kept fully activated.¿ ¿do not use excessive force to deploy the stent.If excessive resistance is felt when beginning deployment, remove the delivery system without deploying the stent and replace with a new device.¿ image review : images were provided to support the complaint investigation.They were reviewed through cook research inc.(cri) and the following comments were provided by the independent reviewer.Impression: implantation of the left superficial femoral artery (sfa) zisv6-35-125-6-140-ptx in a stretched state is confirmed.The stretching involved a 3cm segment of mid proximal stent.This is consistent with successfully deployment of more than half the stent before the retraction sheath and ribbon separated.The proximal most 3cms deployed without significant stretch.Given an overall deployed stent length of 14.5cm, the length of the stretched segment was doubled.Severe tortuosity and calcification would have increased retraction ribbon friction.Root cause review: a definitive root cause could not be determined as the circumstances of use cannot be replicated in the laboratory.A possible root cause could be attributed to the use of a non-recommended wire guide with the device.The use of a non-recommended wire guide with the device may have resulted in insufficient device support during advancement and/or attempted deployment.Insufficient device support may have caused and/or contributed to increased forces on the srs during attempted deployment resulting in the retraction wire separating from the srs during deployment.From the information provided and from the imaging review, it is known that the patient exhibited a severely tortuous and calcified anatomy.It is possible that the difficult patient anatomy may have caused and/or contributed to resistance during advancement.This resistance may also have contributed to the forces exerted on the srs during deployment contributing to separation of the retraction wire from the srs.Summary: complaint is confirmed as the failure was verified in the laboratory.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
|